Online citations, reference lists, and bibliographies.
← Back to Search

Long-term Results And Complications Of Botulinum A Toxin In The Treatment Of Blepharospasm.

J. Dutton, E. Buckley
Published 1988 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The authors review their long-term results and complications with the use of botulinum A toxin in the treatment of facial dystonias. Two hundred thirty-two patients in three diagnostic groups--essential blepharospasm, hemifacial spasm, and Meige's syndrome--were treated with botulinum A toxin. A total of 1044 treatments were given over a 4-year period. A reduction in orbicularis spasm intensity was noted in 1012 (96.9%) treatments (mean duration, 13.3 weeks). There was no clear relationship between toxin dose and the amount of spasm reduction or duration of response, and average duration of beneficial effect remained constant from the first through the twelfth injections. Complications occurred in 236 (22.6%) treatments. In most cases, these were local and transient. Symptomatic dry eye was the most common side effect, noted in 7.5% of cases. Ptosis was reported in 7.3% of treatments and photophobia in 2.5%. Diplopia involving the inferior oblique or lateral rectus muscles was seen in less than 1% of cases. There were no differences in degree of response or in complications among the three diagnostic groups, although there was a slight difference in duration of effect. Patients who had undergone previous eyelid surgery for blepharospasm did not respond differently from those without prior surgery.
This paper references
10.1001/ARCHNEUR.1986.00520090006004
Blepharospasm with basal ganglia lesions.
J. Jankovic (1986)
10.1016/S0161-6420(80)35127-0
Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.
A. B. Scott (1980)
10.1001/ARCHOPHT.1985.01050090057031
Hemifacial spasm treated with botulinum A toxin injection.
P. Savino (1985)
10.1212/WNL.36.4.545
Botulinum toxin for blepharospasm: single-fiber EMG studies
D. Sanders (1986)
10.1016/0002-9394(85)90228-4
Treatment of blepharospasm with botulinum toxin.
E. A. Tsoy (1985)
10.1001/ARCHNEUR.1986.00520040060020
Botulinum toxin in the management of blepharospasm.
J. Dutton (1986)
10.1016/S0161-6420(87)33458-X
Hemifacial spasm. Results of unilateral myectomy.
P. Garland (1987)
10.1212/WNL.37.4.616
Botulinum A toxin for cranial‐cervical dystonia
J. Jankovic (1987)
10.1016/S0161-6420(87)33338-X
Effectiveness of botulinum toxin therapy for essential blepharospasm.
P. Engstrom (1987)
10.1002/ANA.410130406
Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patients
J. Jankovic (1983)
10.1016/0002-9394(86)90601-X
Absence of antibody production in patients treated with botulinum A toxin.
A. W. Biglan (1986)
10.1016/0002-9394(85)90797-4
Sequelae of botulinum toxin injection.
R. Lingua (1985)
10.1001/ARCHOPHT.1981.03930011056015
Blepharospasm surgery. An anatomical approach.
W. Gillum (1981)
10.1097/00002826-198610000-00002
Botulinum injection therapy for blepharospasm: a review and report of 75 patients.
D. Cohen (1986)
10.1001/ARCHOPHT.1984.01040031184014
Treatment of blepharospasm with botulinum toxin. A preliminary report.
B. Frueh (1984)
10.1016/S0733-8619(18)31090-9
The varied clinical expressions of dystonia.
S. Fahn (1984)
10.1016/S0002-7154(67)50584-7
Differential section of the facial nerve for blepharospasm.
D. H. Reynolds (1967)
10.1016/S0161-6420(86)33520-6
Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm.
C. Burns (1986)
10.1016/S0161-6420(86)33785-0
The use of botulinum toxin in the medical management of benign essential blepharospasm.
K. I. Perman (1986)
10.1016/S0002-9394(14)77954-1
The use of botulinum toxin in blepharospasm.
N. Shorr (1985)
Neurological surgery;: A comprehensive reference guide to the diagnosis and management of neurosurgical problems,
J. Youmans (1973)
10.1097/00002341-198601050-00003
Orbicularis muscle pathology after botulinum toxin injection.
T. Wojno (1986)
10.3928/1542-8877-19861101-11
Botulinum toxin for the treatment of essential blepharospasm.
J. Shore (1986)
10.1016/S0161-6420(86)33641-8
Treatment of facial spasm with botulinum toxin. An interim report.
B. Frueh (1986)
10.1227/00006123-198308000-00006
Hemifacial spasm: treatment by microsurgical facial nerve decompression.
J. Loeser (1983)
10.1212/WNL.35.10.1499
Blepharospasm, Meige syndronfie, and hemifacial Spasm
J. Mauriello (1985)
10.1016/S0161-6420(87)33337-8
Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.
J. Mauriello (1987)
10.1001/ARCHOPHT.1984.01040030216030
Treatment of essential blepharospasm. I. Comparison of facial nerve avulsion and eyebrow-eyelid muscle stripping procedure.
C. McCord (1984)
10.1017/S0317167100026159
Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion.
J. Carruthers (1987)
Botulinum toxin injection of eye muscles to correct strabismus.
A. B. Scott (1981)
10.1097/00002341-198601060-00005
Treatment of Hemifacial Spasm with Botulinum A Toxin: Results and Rationale
R. Gonnering (1986)
10.1001/ARCHOPHT.1985.01050030043017
Botulinum A toxin injection as a treatment for blepharospasm.
A. Scott (1985)



This paper is referenced by
10.1136/bjo.87.1.54
Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye
J. Horwath-Winter (2003)
10.1016/B978-0-323-05714-1.00014-5
Functions of the Orbit and Eyelids
Gregory J. Griepentrog (2011)
10.1590/S0034-72802012000600004
Eficácia do resfriamento da pele no alívio da dor desencadeada pela injeção de toxina botulínica tipo A nas distonias faciais
P. Monteiro (2012)
10.1016/B978-0-323-09176-3.00033-4
24 – Esthetics and dermatologic pharmaceuticals
Zev Schulhof (2015)
10.2174/138161209789271843
Current clinical applications of botulinum toxin.
D. Truong (2009)
10.1016/S0733-8619(18)30311-6
Botulinum toxin therapy.
P. Savino (1991)
10.3171/JNS.1995.82.2.0201
Microvascular decompression for hemifacial spasm.
F. Barker (1995)
10.1016/J.SURVOPHTHAL.2006.10.003
Botulinum toxin in ophthalmology.
J. Dutton (2007)
10.1159/000066186
Anesthesia with EMLA® Cream for Botulinum A Toxin Injection into Eyelids
M. Söylev (2002)
10.1136/BJO.74.5.309
Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm.
P. Corridan (1990)
Usefulness of Botulinum Toxin Injection in Rehabilitation of Facial Paralysis: Improving Mouth Angle Asymmetry
Chang Kee Hong (2007)
TFOS DEWS II iatrogenic report Jos e
A. P. Gomes (2017)
10.1016/j.jtos.2017.05.004
TFOS DEWS II iatrogenic report.
José A P Gomes (2017)
10.1016/S0896-1549(05)70230-3
COSMETIC EYELID SURGERY
Samuel A. Gallo (2000)
10.1590/S0034-72802011000200003
Eficácia da aplicação da pomada EMLA® no alivio da dor desencadeada pela injeção de toxina botulínica tipo A no tratamento do blefaroespasmo essencial benigno
Nadia Ajub Moysés (2011)
10.1007/s12640-012-9314-y
Efficacy and Safety of Long-term Botulinum Toxin Treatment in Craniocervical Dystonia: A Systematic Review
C. Colosimo (2012)
10.1016/S0161-6420(97)30220-6
Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
J. Price (1997)
10.1136/bjo.2006.097089
Bilateral upper eyelid ectropion associated with blepharospasm
S. Koh (2006)
10.1167/IOVS.05-0380
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
O. Suwan-apichon (2006)
10.1097/01.iop.0000217382.33972.c4
Myobloc® for the Treatment of Benign Essential Blepharospasm in Patients Refractory to Botox®
J. Dutton (2006)
10.1097/00041327-199412000-00004
Chemomyectomy of the Orbicularis Oculi Muscles for the Treatment of Localized Hemifacial Spasm
J. Wirtschafter (1994)
10.4103/2152-7806.179545
Descompresión microvascular en espasmo hemifacial: Reporte de 13 casos y revisión de la literatura
Alvaro Veizaga Campero (2016)
10.1016/0039-6257(91)90207-V
Botulinum A toxin (Oculinum) in ophthalmology.
M. Osako (1991)
10.1007/BF00839206
Treatment of spasmodic torticollis with local injections of botulinum toxin
W. Poewe (2004)
10.1007/978-3-030-50691-9
Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine
B. Jabbari (2020)
ESANSİYEL BLEFAROSPAZMA BAĞLI FONKSİYONEL KÖRLÜĞÜN KİMYASAL DENERVASYONLA TEDAVİSİ
E. Başar (2003)
10.1016/J.OTC.2005.03.005
Botulinum toxin management of upper facial rhytidosis and blepharospasm.
S. Seiff (2005)
10.1093/med/9780190603953.003.0033
Benign Essential Blepharospasm
M. Thurtell (2011)
10.1097/00004397-200204000-00011
Benign essential blepharospasm.
J. McCann (2002)
10.5897/AJPP12.1060
Clinical efficacy of Neuronox ® botulinum toxin treatment in hemifacial spasm patients
Somsak Tiamkao (2012)
10.1007/978-1-4939-1544-6_139
Management of Benign Essential Blepharospasm
Julie A. Woodward (2015)
10.1177/000348949410300105
Treatment of Dysfunction of the Cricopharyngeal Muscle with Botulinum a Toxin: Introduction of a New, Noninvasive Method
I. Schneider (1994)
See more
Semantic Scholar Logo Some data provided by SemanticScholar